HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Patton, J. T. Articles by Wertz, G. W. Search for Related Content PubMed PubMed Citation Articles by Patton, J. T. Articles by Wertz, G. W. Agricola Articles by Patton, J. T. Articles by Wertz, G. W.

Inhibition of Vesicular Stomatitis Virus RNA Synthesis by 2',3'-Dideoxycytidine 5'-Triphosphate

Department of Bacteriology and Immunology, Medical School, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27514, U.S.A.

The ability of the compound 2',3'-dideoxycytidine 5'-triphosphate (ddCTP) to serve as an inhibitor of viral RNA synthesis was examined using an in vitro system that supports vesicular stomatitis virus (VSV) protein synthesis, transcription and replication. Viral RNA synthesis was inhibited by 87 and 98% of control, respectively, in reactions containing 1 mM- and 10 mM-ddCTP in place of CTP. VSV RNA replication and transcription were inhibited equally by ddCTP. At a concentration of 1 mM-ddCTP, there was no inhibitory effect on viral protein synthesis; at 10 mM-ddCTP, total protein synthesis was inhibited by 30% as compared to control reactions. The presence of ddCTP had no effect on the size or relative molar amounts of each protein synthesized as analysed by electrophoresis on polyacrylamide gels. This is the first report describing a compound that will inhibit VSV RNA synthesis in vitro without compromising the concurrent synthesis and modification of proteins.

Keywords: VSV, ddCTP, RNA synthesis inhibition

Received 7 October 1982; accepted 1 November 1982.